Cognitive impairment in depression: recent advances and novel treatments
Giulia Perini,1,2 Matteo Cotta Ramusino,1,2 Elena Sinforiani,1 Sara Bernini,1 Roberto Petrachi,3 Alfredo Costa1,21Center of Cognitive and Behavioral Disorders, IRCCS Fondazione Mondino, National Institute of Neurology, Pavia, Italy; 2Department of Brain and Behavior, University of Pavia, Pavia, Ital...
Enregistré dans:
Auteurs principaux: | Perini G, Cotta Ramusino M, Sinforiani E, Bernini S, Petrachi R, Costa A |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/074d8d4d7d934a26b55a54f89ef1d1ab |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Evaluation of cognitive impairment in patients with major depressive disorder in remission
par: Mustafa Ali, et autres
Publié: (2021) -
Mind your state: Insights into antidepressant nonadherence
par: De Wet Wolmarans, et autres
Publié: (2016) -
Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder
par: McIntyre RS, et autres
Publié: (2021) -
The efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder: a meta-analysis of randomized controlled trials
par: Li G, et autres
Publié: (2016) -
5-HTR1A and 5-HTR2A genetic polymorphisms and SSRI antidepressant response in depressive Chinese patients
par: Dong ZQ, et autres
Publié: (2016)